Insider Stock Trading History of Venbio Global Strategic Fund Ii L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Venbio Global Strategic Fund Ii L.p. since year 2005. The trader's CIK number is 1634632. At the time of this reporting, Venbio Global Strategic Fund Ii L.p. is the 10% Owner of Menlo Therapeutics, Inc. . (stock ticker symbol MNLO). See this page for all insider trading activities at Menlo Therapeutics, Inc. .

Note that in the past venBio Global Strategic Fund II L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Venbio Global Strategic Fund Ii L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-25 MNLO Menlo Therapeutics, Inc. Buy 265,000 17.00 4,505,000
2017-11-13 APLS Apellis Pharmaceuticals, Inc. Buy 127,515 14.00 1,785,210

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Venbio Global Strategic Fund Ii L.p. (10% Owner of Menlo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.